Page last updated: 2024-08-24

2',3'-dideoxythymidine and vidarabine

2',3'-dideoxythymidine has been researched along with vidarabine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broder, S; Mitsuya, H1
Kumar, A; Nakatsugawa, S; Sugahara, T1

Other Studies

2 other study(ies) available for 2',3'-dideoxythymidine and vidarabine

ArticleYear
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
    Proceedings of the National Academy of Sciences of the United States of America, 1986, Volume: 83, Issue:6

    Topics: Antiviral Agents; Carbohydrate Conformation; Cell Division; Cytopathogenic Effect, Viral; Deltaretrovirus; Deoxyadenosines; Deoxycytidine; Deoxyribonucleosides; Dideoxyadenosine; Dideoxynucleosides; Gene Products, gag; Humans; Lymphocyte Activation; Mitogens; Retroviridae Proteins; Structure-Activity Relationship; T-Lymphocytes; Thymidine; Vidarabine; Zalcitabine

1986
Purine nucleoside analogues inhibit the repair of radiation-induced potentially lethal damage in mammalian cells in culture.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1982, Volume: 41, Issue:3

    Topics: Animals; Cells, Cultured; Cricetinae; Cricetulus; Deoxycytidine; Deoxyguanosine; Deoxyuridine; Dideoxynucleosides; DNA Repair; Dose-Response Relationship, Drug; Purine Nucleosides; Thymidine; Vidarabine

1982